Pricing: $230 Members | $280 Non-Members

Training a team? 
Save with bulk pricing. Contact amcplearn@amcp.org for group rates. 

RWE Essentials Training Program - Life Sciences Version with Additional Module

Program Overview

Turn real-world evidence from buzzword into decision-making power. 

The RWE Training Program gives you the frameworks to evaluate, interpret, and apply real-world evidence using the same criteria payers use for formulary, coverage, and contracting decisions: AMCP RWE Standards.  

What You'll Master: 

✔ RWE vs. RCTs: when and how to use each 
✔ Real-world data sources (claims, EHRs, registries, wearables) 
✔ Study design, bias control, and confounding factors 
✔ Legal, ethical, and regulatory frameworks (FDA guidance, privacy laws) 
✔ AMCP RWE Standards Framework and Checklist 
✔ Evaluating RWE for quality, relevance, and transparency 
✔ Applying RWE to formulary and coverage decisions 
✔ Operationalizing RWE for budget impact models, value-based contracts, and payer engagement 
✔ Communicating RWE findings to payers with credibility 

Perfect for: 
Payers and health plan professionals • Pharmaceutical and life sciences teams • HEOR leads • Formulary decision-makers • Market access strategists • Anyone evaluating or presenting real-world evidence 

Your proof of progress: 
Earn a digital badge and certificate to share on LinkedIn 

Please note: This program is not accredited for continuing pharmacy education. 

The RWE Essentials Training Program, developed as part of AMCP's RWE Initiative, is supported by the following 2025 sponsors: AbbVie, AstraZeneca, L.P., Bayer, Boehringer Ingelheim Pharmaceuticals, Inc., Genentech Inc., Gilead Sciences, Inc., IQVIA Inc., Jazz Pharmaceuticals, Johnson & Johnson Health Care Companies, KlearTrust, LEO Pharma, Lilly USA, LLC, Merck & Co., Inc., Pfizer Inc., Sanofi, Takeda Pharmaceuticals America, Inc.